EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access

Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis

Yukio Suzuki, Jennifer S Ferris, Ling Chen, Shayan Dioun, John Usseglio, Koji Matsuo, Xiao Xu, Dawn L Hershman, Jason D Wright iD

JNCI: Journal of the National Cancer Institute · 08.05.2024 · 116 (5) · 653-664

DOI: 10.1093/jnci/djae023 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 01.02.2024. Verfasst von Yukio Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University College of Physicians and Surgeons, New York, NY, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Intrauterine Devices, Medicated, Levonorgestrel, Pregnancy Rate. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We conducted a systematic review and meta-analysis to examine outcomes of patients with endometrial intraepithelial neoplasia treated with oral progestins or a levonorgestrel-releasing intrauterine device (IUD).

Methods

We conducted a systematic review across 5 databases to examine outcomes of progestational treatment (oral progestins or levonorgestrel-releasing IUD) for patients with endometrial intraepithelial neoplasia. The primary outcome was the best complete response rate within 12 months of primary progestational treatment. Sensitivity analyses were performed by removing studies with extreme effect sizes. Secondary outcomes included the pooled pregnancy rate.

Results

We identified 21 eligible studies, including 824 premenopausal patients with endometrial intraepithelial neoplasia, for our meta-analysis. Among these, 459 patients received oral progestin, and 365 patients received levonorgestrel-releasing IUD as a primary progestational treatment. The pooled best complete response proportion within 12 months was 82% (95% confidence interval [CI] = 69% to 91%) following oral progestin treatment and 95% (95% CI = 81% to 99%) following levonorgestrel-releasing IUD treatment. After removing outlier studies, the pooled proportion was 86% (95% CI = 75% to 92%) for the oral progestin group and 96% (95% CI = 91% to 99%) for the levonorgestrel-releasing IUD group, with reduced heterogeneity. The pooled pregnancy rate was 50% (95% CI = 35% to 65%) after oral progestin and 35% (95% CI = 23% to 49%) after levonorgestrel-releasing IUD treatment.

Conclusions

This meta-analysis provides data on the effectiveness of oral progestins and levonorgestrel-releasing IUD treatment within 12 months of treatment among premenopausal patients with endometrial intraepithelial neoplasia. Although based on small numbers, the rate of pregnancy after treatment is modest. These data may be beneficial for selecting progestational therapies that allow fertility preservation for patients with endometrial intraepithelial neoplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsIntrauterine Devices, MedicatedLevonorgestrelPregnancy RateProgestinsAdultFemaleHumansPregnancyAdministration, OralCarcinoma in SituTreatment Outcome

Substanzen

LevonorgestrelProgestins

Autor:innen und Institutionen

  • Columbia University College of Physicians and Surgeons, New York, NY, USA.
  • Joseph L. Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
  • New York Presbyterian Hospital, New York, NY, USA.
  • Augustus C. Long Health Sciences Library, Columbia University Irving Medical Center, New York, NY, USA.
  • University of Southern California, Los Angeles, CA, USA.

ORCID-Profile: Jason D Wright

Förderung

  • NIH

Zitieren

APA

Suzuki, Y., Ferris, J. S., Chen, L., Dioun, S., Usseglio, J., Matsuo, K., Xu, X., Hershman, D. L., & Wright, J. D. (2024). Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute, 116(5), 653-664. https://doi.org/10.1093/jnci/djae023

Vancouver

Suzuki Y, Ferris JS, Chen L, Dioun S, Usseglio J, Matsuo K, et al. Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute. 2024;116(5):653-664. doi:10.1093/jnci/djae023

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Yukio and Ferris, Jennifer S and Chen, Ling and Dioun, Shayan and Usseglio, John and Matsuo, Koji and Xu, Xiao and Hershman, Dawn L and Wright, Jason D},
  title = {Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  volume = {116},
  number = {5},
  pages = {653--664},
  doi = {10.1093/jnci/djae023}
}
Kostenlos starten →